Companies / Achieve Life Sciences
Achieve Life Sciences
Seattle, United States
Achieve Life Sciences is a late-stage specialty pharmaceutical company dedicated to tackling the global nicotine dependence epidemic by advancing cytisinicline.
Achieve Life Sciences, based in Seattle, United States, has 2 investors on file, among them venBio and Vivo Capital.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from venBio
21 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (95%), Media & Entertainment (5%).
More from Vivo Capital
83 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (95%), AI & Machine Learning (4%), Legal & Compliance (1%).
Recent changes
what VCinfo saw changeA company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Achieve Life Sciences and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when venBio adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/achievelifesciences.com/investors
# also
GET /v1/companies/achievelifesciences.com
GET /v1/companies/achievelifesciences.com/news